The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II open label nonrandomized safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 immunotherapy in combination with PD-1 checkpoint blockade in intermediate-risk localized or locally advanced prostate cancer and advanced metastatic prostate cancer.
 
Mark Tuthill
Leadership - Personalised Medicine Limited
Honoraria - Bristol-Myers Squibb; Ipsen; Janssen; Lilly; Novartis; Pfizer; Roche; Vaccitech
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen; Lilly; Novartis; Pfizer; Roche; Vaccitech
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Eisai; Everything Genetic; Genomic Health; Janssen; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen
 
Federica Cappuccini
No Relationships to Disclose
 
Richard John Bryant
No Relationships to Disclose
 
Ian Poulton
No Relationships to Disclose
 
Emily Pollock
No Relationships to Disclose
 
Lucy Carter
No Relationships to Disclose
 
Clare Verrill
No Relationships to Disclose
 
Armin Meier
Employment - Definiens
 
Günter Schmidt
Employment - Definiens
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patents and patent applications, and
 
James WF Catto
Honoraria - Abbott Laboratories
Consulting or Advisory Role - AstraZeneca/MedImmune; Ferring; Janssen
Speakers' Bureau - ASCO; AstraZeneca/MedImmune; MSD Oncology; Nucleix; Roche
Travel, Accommodations, Expenses - European Association of Urology
 
Tom Evans
Employment - Vaccitech
Leadership - Vaccitech
Stock and Other Ownership Interests - Vaccitech
Honoraria - VIR Biotechnology
Patents, Royalties, Other Intellectual Property - Vaccitech
 
Silke Gillessen
Honoraria - Janssen
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma (Inst); Bayer (Inst); Clovis Oncology (Inst); Innocrin Pharma (Inst); Janssen (Inst); Menarini Silicon Biosystems (Inst); Orion; Roche; Sanofi; Tolero Pharmaceuticals (Inst); Vaniam Group (Inst)
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
Other Relationship - Aranda Pharma (Inst); ProteoMediX
 
Andrew Protheroe
Consulting or Advisory Role - Bristol-Myers Squibb; EUSA Pharma; Roche
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; EUSA Pharma; MSD
 
Freddie Hamdy
Honoraria - Ferring
Travel, Accommodations, Expenses - Ferring
 
Adrian V.S. Hill
Leadership - Vaccitech
Stock and Other Ownership Interests - Vaccitech
Honoraria - Vaccitech
Patents, Royalties, Other Intellectual Property - Vaccitech
Travel, Accommodations, Expenses - Vaccitech
 
Irina Redchenko
Stock and Other Ownership Interests - Oxford Biomedica
Consulting or Advisory Role - Vaccitech